When oncologic treatment options outpace the existing evidence: Contributing factors and a path forward

Daphne L. van der Velden, Laura A. Levit, George J. Chang, Matthew A. Facktor, Karyn A. Goodman, Jeffrey Kaufman, Gottfried E. Konecny, Sharon W. Kwan, Margaret Mooney, Grace Smith, Stephen B. Solomon, Alda Tam, David Michael Waterhouse, Emile E. Voest